Stock info Supernus Pharmaceuticals Inc | Filter  Basic-Info

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent worldwide over the last 10 years. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year was a good investment year for Supernus Pharmaceuticals Inc investors

The period between December 2015 and December 2016 was a profitable period for the investors in Supernus Pharmaceuticals Inc. The stock gained around 69 percent. Over the past 5 years Supernus Pharmaceuticals Inc' stock lost at around 0 percent in value. Supernus Pharmaceuticals Inc's revenues between 2011 and 2015 were far from constant and moved between 1,48 million dollars and 144,43 million dollars. Supernus Pharmaceuticals Inc's net results between 2011 and 2015 were quite unstable and moved between -23,23 million dollars and 14,02 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Supernus Pharmaceuticals Inc financed with a quite low debt position

At the end of 2015 the pharmaceutical company's balance sheet equaled 188,73 million dollars. 69,85 million dollars (37,01 percent of the total balance sheet) was financed by debt. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 24. So the investors valued the stock at 24 times 2015' earnings per share. We could say that based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the pharmaceutical company equaled around 630,6 million dollars. At the end of 2015 the American company had around 47,49 million stocks listed.

All Supernus Pharmaceuticals Inc's annual reports can be found here. More information about Supernus Pharmaceuticals Inc can be found it's website. .